Relative Efficacy of Alirocumab, Bempedoic Acid, Evolocumab, Ezetimibe and Inclisiran Added to Statins for Reduction of Low Density Lipoprotein Cholesterol - A Network Meta-Analysis of Randomized Clinical Trials

被引：0
|
作者：
Toth, Peter P.
Bray, Sarah
Worth, Gavin
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13503
引用
收藏
页数：2
相关论文
共 50 条
  • [31] RELATIONSHIP BETWEEN PERCENTAGE REDUCTION IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AMONG PATIENTS TREATED WITH STATINS plus /- ALIROCUMAB OR EZETIMIBE IN THE PHASE 3 ODYSSEY TRIALS
    Ray, Kausik
    Ginsberg, Henry
    Davidson, Michael
    Pordy, Robert
    Bessac, Laurence
    Minini, Pascal
    Eckel, Robert
    Cannon, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2082 - 2082
  • [32] The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Jamialahmadi, Tannaz
    Baratzadeh, Fatemeh
    Reiner, Zeljko
    Simental-Mendia, Luis E.
    Xu, Suowen
    Susekov, Andrey V.
    Santos, Raul D.
    Sahebkar, Amirhossein
    MEDIATORS OF INFLAMMATION, 2021, 2021
  • [33] Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention A Meta-analysis of Randomized Clinical Trials
    Lee, Meng
    Chun-Yu Cheng
    Yi-Ling Wu
    Jiann-Der Lee
    Chia-Yu Hsu
    Ovbiagele, Bruce
    JAMA NEUROLOGY, 2022, 79 (04) : 349 - 358
  • [34] Low-density Lipoprotein Cholesterol Reduction Therapies for Secondary Prevention in Patients with Stroke: A Network Meta-analysis
    Wang, Xing
    Zheng, Jun
    Chen, Yuqi
    You, Chao
    Ma, Lu
    CURRENT NEUROPHARMACOLOGY, 2024, 22 (12) : 2034 - 2044
  • [35] Authors' Reply to 'Comment on: Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III Trials'
    Bhagavathula, Akshaya Srikanth
    Al Matrooshi, Nadya Obaid
    Clark, Cain C. T.
    Rahmani, Jamal
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 495 - 496
  • [36] Authors’ Reply to ‘Comment on: Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III Trials’
    Akshaya Srikanth Bhagavathula
    Nadya Obaid Al Matrooshi
    Cain C. T. Clark
    Jamal Rahmani
    Clinical Drug Investigation, 2021, 41 : 495 - 496
  • [37] THE EFFICACY OF EVOLOCUMAB AND OTHER LIPID-LOWERING THERAPIES (LLT) FOR THE MANAGEMENT OF LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C): A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (NMA)
    Worthy, G.
    Gandra, S. R.
    Bridges, I.
    Worth, G.
    Dent, R.
    Cheng, L. I.
    Forbes, C.
    Deshpande, S.
    Ross, J.
    Kleijnen, J.
    Stroes, E. S. G.
    ATHEROSCLEROSIS, 2016, 252 : E56 - E57
  • [38] Author Correction: Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials
    Amirhossein Sahebkar
    Luis E. Simental-Mendía
    Matteo Pirro
    Maciej Banach
    Gerald F. Watts
    Cesare Sirtori
    Khalid Al-Rasadi
    Stephen L. Atkin
    Scientific Reports, 10
  • [39] A Meta-analysis of the Regulation of Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin-Kexin Type 9 with Inclisiran
    Li, Yihan
    Xue, Kefan
    Hu, Rui
    Hu, Xiao
    Guo, Ran
    Guo, Hongxia
    Li, Gang
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (02) : 191 - 201
  • [40] Trial-level surrogacy of non-high-density and low-density lipoprotein cholesterol reduction on the clinical efficacy of statins
    Liaigre, Lea
    Guigui, Alicia
    Manceau, Marc
    Cracowski, Jean-Luc
    Khouri, Charles
    Roustit, Matthieu
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2025,
12345